Başar, M. MuradAydın, GülümserMert, H. ÇağatayKeles, IşıkÇağlayan, OsmanOrkun, SesimBatislam, Ertan2020-06-252020-06-252005closedAccess0090-4295https://doi.org/10.1016/j.urology.2005.03.060https://hdl.handle.net/20.500.12587/3444Batislam, Ertan/0000-0002-7493-4573Objectives. To determine the relationship between the total and subscale scores of the Aging Male Symptoms (AMS) and International Index of Erectile Function (IIEF) questionnaires, age, and serum sex steroids levels. Methods. A total of 348 patients enrolled in the study answered the AMS and IIEF questionnaires. Hormonal analysis, including total testosterone, free testosterone (FT), estradiol (EA and dehydroepiandrosterone-sulphate (DHEA-S) measurement, were performed. The patients with a total AMS score of 29 were considered to have aging male symptoms and the patients with an I IEF score of less than 26 were considered to have sexual dysfunction. Results. Although DHEA-S levels were significantly lower and E-2 levels were greater in the men with aging male symptoms according to the AMS, the DHEA-S and FT levels were significantly lower in the men with sexual dysfunction, as determined by the IIEF score. Serum DHEA-S and FT levels and age correlated significantly with the IIEF scores. The total AMS score correlated significantly only with age. Although serum total testosterone, FT, and DHEA-S levels correlated significantly with the andrologic symptoms of AMS, the serum E-2 levels correlated with psychological symptoms of AMS., Conclusions. Although aging male symptoms and the effects of hormonal changes on these symptoms have been controversial, DHEA-S and E-2 might play some important roles in the symptoms of aging men.eninfo:eu-repo/semantics/closedAccessRelationship between serum sex steroids and Aging Male Symptoms score and International Index of Erectile FunctionArticle66359760110.1016/j.urology.2005.03.0602-s2.0-2414445424716140085Q2WOS:000232157700026Q2